Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics Firm Xagenic today announced that it has raised C$15 million ($11.8 million) in new financing that it hopes will accelerate its efforts to develop and commercialize its point-of-care diagnostic platform.

Headquartered in Toronto, Xagenic has been developing a platform it calls the Xagenic X1 based on a core technology that was originally developed by researchers at the University of Toronto.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.